Clinical Trial: Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854445) titled 'Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma' on Feb. 26.

Brief Summary: The purpose of this study is to assess the preliminary efficacy of TQB2825 in combination with chemotherapy in subjects with diffuse large B-cell lymphoma.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Diffuse Large Cell B-lymphoma

Intervention: DRUG: TQB2825 Injection + Gemcitabine Hydrochloride for Injection + Oxaliplatin for Injection

Drug: TQB2825 Injection + Gemcitabine Hydrochloride for Injection + Oxaliplatin for Injection;

Other Name:

Gemcitabine Hydrochloride...